CD44 and gastric cancer: Similarly in gastric cancer, CD44 3′-UTR was found to be directly targeted by miR-145, with miR-145 overexpression repressing CD44 3′-UTR activity, which could be abrogated by blocking the miR-145/CD44 3′-UTR interaction, supporting significant augmentation of chemotherapy resistance and sphere formation [109].